AI-native biotech firm Baiao Jihui has secured hundreds of millions of yuan in strategic funding, co-led by Shanghai Biomedical Innovation Transformation Fund and Guoke Investment. The capital will fuel the development of its life sciences "micro-world model," GeoFlow, and advance its proprietary drug pipelines. GeoFlow, an AI model, precisely simulates molecular interactions at the atomic level to design novel molecules, aiming to shift from understanding life to designing it. The company has already achieved significant milestones, including matching AlphaFold 3's performance in protein complex prediction and developing de novo design capabilities for antibodies and vaccines. AI
IMPACT Accelerates the development of AI-driven drug discovery and design, potentially reducing R&D timelines and costs.
RANK_REASON Significant funding round for an AI-native biotech company developing a novel life science model. [lever_c_demoted from significant: ic=1 ai=0.7]
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →